Protein kinase c inhibition ameliorates posttransplantation preservation injury in rat renal transplants

Transplantation

Volumn 94, Issue 7, 2012, Pages 679-686

  Fuller, Tom Florian ^a   Kusch, Angelika ^a   Chaykovska, Lyubov ^b   Catar, Rusan ^a   Pützer, Jennifer ^a   Haller, Martina ^c   Troppmair, Jakob ^c   Hoff, Uwe ^a   Dragun, Duska ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

AEB071; Kidney transplantation; Preservation reperfusion injury; Rat; Sotrastaurin

Indexed keywords

CELL ADHESION MOLECULE; CREATININE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID; PROTEIN KINASE C DELTA; PROTEIN KINASE C THETA; PROTEIN SHC; SERINE; SOTRASTAURIN; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL PROTECTION; CELL STRESS; COLD ISCHEMIA; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; GENE; GENE SEQUENCE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INJURY SEVERITY; INOS 1 GENE; INTRACELLULAR SIGNALING; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; MALE; MCP 1 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VCAM 1 GENE; WESTERN BLOTTING;

ADENOSINE; ALLOPURINOL; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL PROLIFERATION; COLD TEMPERATURE; CREATININE; CYTOKINES; CYTOPROTECTION; DELAYED GRAFT FUNCTION; GLUTATHIONE; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INSULIN; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PYRROLES; QUINAZOLINES; RAFFINOSE; RATS; RATS, INBRED LEW; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84867267248     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318265c4d8     Document Type: Article

References (49)

1. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006; 21: 1689.
2. Perico N, Cattaneo D, Sayegh MH, et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814.
3. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
4. Remuzzi G, Perico N. Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int Suppl 1995; 52: S70.
5. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481.
6. Cravedi P, Ruggenenti P, Remuzzi G. Sirolimus for calcineurin inhibitors in organ transplantation: contra. Kidney Int 2010; 78: 1068.
7. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.
8. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int 2003; 64: 864.
9. Fuller TF, Hoff U, Rose F, et al. Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation. Kidney Int 2006; 70: 570.
10. Peeters P, Vanholder R. Therapeutic interventions favorably influencing delayed and slow graft function in kidney transplantation: mission impossible? Transplantation 2008; 85(7 suppl): S31.
11. Evenou JP, Wagner J, Zenke G, et al. The potent protein kinase Cselective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation. J Pharmacol Exp Ther 2009; 330: 792.
12. Skvara H, Dawid M, Kleyn E, et al. The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J Clin Invest 2008; 118: 3151.
13. Matz M, Weber U, Mashreghi MF, et al. Effects of the new immunosuppressive agent AEB071 on human immune cells. Nephrol Dial Transplant 2010; 25: 2159.
14. Weckbecker G, Pally C, Beerli C, et al. Effects of the novel protein kinase C inhibitor AEB071 (sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720. Transpl Int 2010; 23: 543.
15. Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev 2008; 88: 1341.
16. Sivaraman V, Hausenloy DJ, Kolvekar S, et al. The divergent roles of protein kinase C epsilon and delta in simulated ischaemia-reperfusion injury in human myocardium. J Mol Cell Cardiol 2009; 46: 758.
17. Fuller TF, Hoff U, Kong L, et al. Cytoprotective actions of FTY720 modulate severe preservation reperfusion injury in rat renal transplants. Transplantation 2010; 89: 402.
18. Dragun D, Hoff U, Park JK, et al. Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function. Kidney Int 2001; 60: 1173.
19. Schonwasser DC, Marais RM, Marshall CJ, et al. Activation of the mitogen-activated protein kinase/extracellular signalYregulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 1998; 18: 790.
20. Sun L, Xiao L, Nie J, et al. p66Shc mediates high-glucose and angiotensin IIYinduced oxidative stress renal tubular injury via mitochondrialdependent apoptotic pathway. Am J Physiol Renal Physiol 2010; 299: F1014.
21. Morita M, Matsuzaki H, Yamamoto T, et al. Epidermal growth factor receptor phosphorylates protein kinase C {delta} at Tyr332 to form a trimeric complex with p66Shc in the H2O2-stimulated cells. J Biochem 2008; 143: 31.
22. Zundorf G, Reiser G. The phosphorylation status of extracellularregulated kinase 1/2 in astrocytes and neurons from rat hippocampus determines the thrombin-induced calcium release and ROS generation. J Neurochem 2011; 119: 1194.
23. Pellegrini M, Pacini S, Baldari CT. p66SHC: the apoptotic side of Shc proteins. Apoptosis 2005; 10: 13.
24. Matsumoto Y, Hof A, Baumlin Y, et al. Efficacy of mycophenolate sodium as monotherapy and in combination with FTY720 in a DAto-Lewis-rat heart-transplantation model. Transplantation 2002; 74: 1372.
25. Gonzalez N, Alvarez V, Pons H, et al. Mycophenolate mofetil aggravates postischemic acute renal failure in rats. Transplant Proc 2002; 34: 43.
26. Daemen MA, van 't Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999; 104: 541.
27. Giorgio M, Migliaccio E, Orsini F, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005; 122: 221.
28. Cosentino F, Francia P, Camici GG, et al. Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. Arterioscler Thromb Vasc Biol 2008; 28: 622.
29. Padanilam BJ. Induction and subcellular localization of protein kinase C isozymes following renal ischemia. Kidney Int 2001; 59: 1789.
30. Fujita T, Asai T, Andrassy M, et al. PKCbeta regulates ischemia/reperfusion injury in the lung. J Clin Invest 2004; 113: 1615.
31. Yin T, Sandhu G, Wolfgang CD, et al. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 1997; 272: 19943.
32. Thabard W, Collette M, Bataille R, et al. Protein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells. Biochem J 2001; 358(pt 1): 193.
33. Van Keymeulen A, Roger PP, Dumont JE, et al. TSH and cAMP do not signal mitogenesis through Ras activation. Biochem Biophys Res Commun 2000; 273: 154.
34. Chiloeches A, Paterson HF, Marais R, et al. Regulation of Ras.GTP loading and Ras-Raf association in neonatal rat ventricular myocytes by G proteinYcoupled receptor agonists and phorbol ester. Activation of the extracellular signalYregulated kinase cascade by phorbol ester is mediated by Ras. J Biol Chem 1999; 274: 19762.
35. Clark JS, Faisal A, Baliga R, et al. Cisplatin induces apoptosis through the ERK-p66shc pathway in renal proximal tubule cells. Cancer Lett 2010; 297: 165.
36. Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase C delta. Apoptosis 2003; 8: 19.
37. Majumder PK, Pandey P, Sun X, et al. Mitochondrial translocation of protein kinase C delta in phorbol esterYinduced cytochrome c release and apoptosis. J Biol Chem 2000; 275: 21793.
38. Li X, Pabla N, Wei Q, et al. PKC-delta promotes renal tubular cell apoptosis associated with proteinuria. J Am Soc Nephrol 2010; 21: 1115.
39. Lee JS, Yang EJ, Kim IS. The roles of MCP-1 and protein kinase C delta activation in human eosinophilic leukemia EoL-1 cells. Cytokine 2009; 48: 186.
40. Lin WN, Luo SF, Lin CC, et al. Differential involvement of PKCdependent MAPKs activation in lipopolysaccharide-induced AP-1 expression in human tracheal smooth muscle cells. Cell Signal 2009; 21: 1385.
41. Nagy B Jr, Bhavaraju K, Getz T, et al. Impaired activation of platelets lacking protein kinase C-theta isoform. Blood 2009; 113: 2557.
42. Molitoris BA, Sutton TA. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int 2004; 66: 496.
43. Kamo N, Shen XD, Ke B, et al. Sotrastaurin, a protein kinase C inhibitor, ameliorates ischemia and reperfusion injury in rat orthotopic liver transplantation. Am J Transplant 2011; 11: 2499.
44. Friman S, Arns W, Nashan B, et al. Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. Am J Transplant 2011; 11: 1444.
45. Meier-Kriesche HU, Kaplan B. The search for CNI-free immunosuppression: no free lunch. Am J Transplant 2011; 11: 1355.
46. Rao PS, Ojo A. The alphabet soup of kidney transplantation: SCD, DCD, ECDVfundamentals for the practicing nephrologist. Clin J Am Soc Nephrol 2009; 4: 1827.
47. Hoff U, Lukitsch I, Chaykovska L, et al. Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury. Kidney Int 2011; 79: 57.
48. Karatas A, Hegner B, deWindt LJ, et al. Deoxycorticosterone acetateYsalt mice exhibit blood pressureYindependent sexual dimorphism. Hypertension 2008; 51: 1177.
49. Gurgen D, Hegner B, Kusch A, et al. Estrogen receptor-beta signals left ventricular hypertrophy sex differences in normotensive deoxycorticosterone acetateYsalt mice. Hypertension 2011; 57: 648.